Gerry Smith

The new version of Moderna Inc.'s Covid-19 vaccine hit its goal in a late-stage trial, the company said, helping pave the way for a shot that's easier to use and more potent for the elderly.

Verve Therapeutics Inc. shares tumbled in premarket trading after it cited safety concerns for pausing enrollment in a study of its gene-editing treatment for people with high cholesterol, delivering a setback to the promising new field of medicine.

(Bloomberg) -- Verve Therapeutics Inc. shares tumbled in premarket trading after it cited safety concerns for pausing enrollment in a study of its

(Bloomberg) — Verve Therapeutics Inc. shares tumbled after it cited safety concerns for pausing enrollment in a study of its gene-editing treatment

Hi folks, it’s Gerry in New York. Princess Kate just reminded the world how hard it can be to disclose an illness. But first…

Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total equity value of about $4.9 billion, adding the biotech company’s immune treatments to its growing pipeline.

Intra-Cellular Therapies Inc. soared the most in more than two years after its top-selling drug succeeded in a trial of major depressive disorder, potentially opening up a lucrative new market.

Biogen Inc. reported first-quarter profit that beat Wall Street's expectations, as the biotech giant cut costs and its new Alzheimer's drug Leqembi gained momentum.

Biogen Beats Estimates as Alzheimer's Drug Gains Traction

(Bloomberg) -- Biogen Inc. reported first-quarter profit that beat Wall Street’s expectations as the biotech giant’s new Alzheimer’s drug Leqembi gained traction and cost cuts took hold.Most Read from BloombergTaylor Swift Is Proof That How We Critique Music Is BrokenBiden’s New Chopper Is Demoted After Scorching White House LawnBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsTesla Soars as Musk’s Cheaper EVs Calm Fears Over StrategyBillionaire Pinaults Fight to Pull Guc